Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holger Hebart

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
Annals of Hematology|September 19, 2003
Sepsis in neutropenia--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)Xaver Schiel, Holger Hebart, Winfried V Kern, et al.
Pediatric Blood & Cancer|March 8, 2018
CNS progression during vinblastine or targeted therapies for high-risk relapsed ALK-positive anaplastic large cell lymphoma: A case seriesStephanie Ruf, Holger Hebart, Lisa Lyngsie Hjalgrim, et al.
British Journal of Haematology|October 3, 2002
Human cytomegalovirus induces a direct inhibitory effect on antigen presentation by monocyte-derived immature dendritic cellsUlrich Grigoleit, Susanne Riegler, Hermann Einsele, et al.
Advances in Therapy|January 29, 2019
Prospective Observational Cohort Study to Describe the Use of Panitumumab in Combination with Chemotherapy in Real-World Clinical Practice for Patients with Wild-Type RAS mCRCHolger Hebart, Michael Kiehl, Jiri Tomasek, et al.
European Journal of Cancer (Oxford, England : 1990)|December 3, 2011
Response prediction in metastasised colorectal cancer using intratumoural thymidylate synthase: results of a randomised multicentre trialMarko Kornmann, Holger Hebart, Kathleen Danenberg, et al.
Haematologica|November 4, 2005
Mucormycoses in patients with hematologic malignancies: an emerging fungal infectionWolfgang A Bethge, Marc Schmalzing, Gernot Stuhler, et al.
Blood|December 15, 2005
Oral valganciclovir leads to higher exposure to ganciclovir than intravenous ganciclovir in patients following allogeneic stem cell transplantationHermann Einsele, Pierre Reusser, Martin Bornhäuser, et al.
Visceral Medicine|June 14, 2019
Adjuvant Chemotherapy of Locally Advanced Colon Cancer: Final Results of a Randomized Trial Comparing 5-Fluorouracil and Folinic Acid with FolfiriStephan Paschke, Holger Hebart, Roland Goeb, et al.
British Journal of Haematology|April 29, 2003
Follow-up of patients with progressive multiple myeloma undergoing allografts after reduced-intensity conditioningHermann Einsele, Hans-Jörg Schäfer, Holger Hebart, et al.
Blood|October 24, 2002
Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignanciesHolger Hebart, Claudia Bollinger, Paul Fisch, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Annals of Hematology|September 19, 2003
Sepsis in neutropenia--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)Xaver Schiel, Holger Hebart, Winfried V Kern, et al.
Pediatric Blood & Cancer|March 8, 2018
CNS progression during vinblastine or targeted therapies for high-risk relapsed ALK-positive anaplastic large cell lymphoma: A case seriesStephanie Ruf, Holger Hebart, Lisa Lyngsie Hjalgrim, et al.
British Journal of Haematology|October 3, 2002
Human cytomegalovirus induces a direct inhibitory effect on antigen presentation by monocyte-derived immature dendritic cellsUlrich Grigoleit, Susanne Riegler, Hermann Einsele, et al.
Advances in Therapy|January 29, 2019
Prospective Observational Cohort Study to Describe the Use of Panitumumab in Combination with Chemotherapy in Real-World Clinical Practice for Patients with Wild-Type RAS mCRCHolger Hebart, Michael Kiehl, Jiri Tomasek, et al.
European Journal of Cancer (Oxford, England : 1990)|December 3, 2011
Response prediction in metastasised colorectal cancer using intratumoural thymidylate synthase: results of a randomised multicentre trialMarko Kornmann, Holger Hebart, Kathleen Danenberg, et al.
Haematologica|November 4, 2005
Mucormycoses in patients with hematologic malignancies: an emerging fungal infectionWolfgang A Bethge, Marc Schmalzing, Gernot Stuhler, et al.
Blood|December 15, 2005
Oral valganciclovir leads to higher exposure to ganciclovir than intravenous ganciclovir in patients following allogeneic stem cell transplantationHermann Einsele, Pierre Reusser, Martin Bornhäuser, et al.
Visceral Medicine|June 14, 2019
Adjuvant Chemotherapy of Locally Advanced Colon Cancer: Final Results of a Randomized Trial Comparing 5-Fluorouracil and Folinic Acid with FolfiriStephan Paschke, Holger Hebart, Roland Goeb, et al.
British Journal of Haematology|April 29, 2003
Follow-up of patients with progressive multiple myeloma undergoing allografts after reduced-intensity conditioningHermann Einsele, Hans-Jörg Schäfer, Holger Hebart, et al.
Blood|October 24, 2002
Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignanciesHolger Hebart, Claudia Bollinger, Paul Fisch, et al.
Pageof 7